CA
NZ
UK
AU
IND
US
IRT is a multifamily apartment REIT with a portfolio of 115 operating properties and 33,398 units at quarter end. Rental and other property revenue was $172.0 million, up about 3.0% from $166.9 million a year ago (calculated).
The firm is a global technology research and advisory company that helps clients with sourcing, technologyInvestmentdecisions and the governance of provider relationships, and it has about 1,500 professionals. Management said it pivoted to an AI-centered model roughly two years ago.
Net income attributable to common stockholders was $28.7 million, or $0.99 per diluted share, compared with $28.3 million, or $0.97. Normalized FFO was $50.2 million, or $1.80 per share, up from $1.60. AFFO reached $54.8 million, or $1.96 per share, which is about 14.6% …
The company makes the Inspire system, a hypoglossal nerve stimulation therapy for patients with moderate to severe obstructive sleep apnea. Management attributed the decline mainly to billing and reimbursement uncertainty around the latest Inspire V device and estimated that coding and reimbursement problems cost …
The company still posted a net loss of $0.02 per share, versus net income of $0.01 a year earlier. Net loss was $5.6 million, asDepreciationand amortization jumped to $78.7 million from $30.9 million after the wave of purchases.Transaction Costsadded $3.4 million.
The Irish-incorporated company develops medicines for rare diseases, with a portfolio spanning sleep disorders, epilepsy and cancer. Xywav net sales increased 12% to $483 million after about 425 net patient additions, while Epidiolex sales were $295 million. Management said Epidiolex growth was held back …
Kosmos is a deepwater exploration and production company with output offshore Ghana, Mauritania, Senegal and the Gulf of America. Sales volumes were 62,437 barrels of oil equivalent per day, versus 59,942, despite the June 2026 sale of its Equatorial Guinea assets.
Krystal is a commercial-stage company that develops gene therapies, and Vyjuvek treats dystrophic epidermolysis bullosa, a rare genetic skin disease. US net revenue was $95.3 million, supported by more than 760 reimbursement approvals and over 80 new prescribers added in the quarter. About 80% …
Management said FPGA revenue grew about 90% year over year, fueled by data center AIDemandand a recovery in industrial and embedded markets. Compute and Communications revenue reached $171.9 million, up from $74.0 million a year earlier, a gain of about 132% (calculated). Industrial and …
For the first nine months, net income was $1,087 million, or $5.29 per share, versus $1,265 million, or $6.03. The weighted average diluted share count declined to 204.57 million in the quarter from 207.71 million.
Please wait processing your request...